Core Insights - Equasens Group reported a total revenue of €216.8 million for the year ending December 31, 2024, reflecting a decrease of 1.4% on a reported basis and a decline of 3.7% on a like-for-like basis [3][4][11] Revenue Breakdown - Q4 2024 revenue was €58.6 million, representing a 2.6% increase on a reported basis but a 0.4% decrease on a like-for-like basis compared to Q4 2023 [3][10][11] - The Pharmagest Division generated €163.5 million in revenue for 2024, a slight increase of 0.5% on a reported basis, but a decline of 3.3% on a like-for-like basis [5][11] - The Axigate Link Division achieved €32.1 million in revenue for 2024, marking a 3.2% increase on a reported basis and a 5.5% increase on a like-for-like basis [11][12] - The e-Connect Division saw a significant decline, with revenue of €11.2 million for 2024, down 25.3% on a reported basis [11][24] - The Medical Solutions Division recorded revenue of €7.9 million for 2024, down 10.9% compared to the previous year [11][24] - The Fintech Division's revenue was €2.0 million for the year, a decrease of 2.1% compared to 2023 [11][24] Strategic Developments - Equasens Group is focusing on a strategic transformation towards a SaaS business model, which includes migrating solutions to cloud-based platforms [20][21] - The company is investing in Artificial Intelligence to enhance its decision-making tools for healthcare professionals [21] - The acquisition of Calimed SAS in December 2024 aligns with the company's strategy of external growth [4][11] Market Conditions - The company faced challenges due to political instability in France, impacting configuration and equipment sales, which decreased by 7.9% for the full year [11] - Despite these challenges, scalable maintenance services and professional training showed positive growth, with a 3.1% increase in Q4 2024 [11] Future Outlook - The company anticipates a positive momentum for 2025, expecting nearly 10% nominal growth in the second half of the year driven by new solutions and capital expenditures [19][20]
Equasens: 2024 annual revenue